| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $14.0M | +14.8% |
| Cost of Revenue | $15.0M | +20.9% |
| Gross Profit | -$965K | -440.3% |
| R&D Expense | $162K | +0.8% |
| SG&A Expense | $10.8M | -7.3% |
| Operating Income | -$12.6M | -0.4% |
| Pre-tax Income | -$12.7M | -0.9% |
| Income Tax | $2K | +0.0% |
| Net Income | -$12.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.9M | +179.6% |
| Accounts Receivable | $132K | +37.0% |
| Current Assets | $6.4M | +99.6% |
| Total Assets | $10.8M | +88.1% |
| Current Liabilities | $3.8M | -45.5% |
| Total Liabilities | $4.3M | -55.7% |
| Stockholders' Equity | $6.5M | +265.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.2M | -117.4% |
| Capital Expenditures | $4K | +0.0% |
| Investing Cash Flow | -$2.4M | -1161.5% |
| Financing Cash Flow | $14.4M | +216.8% |
| Free Cash Flow | -$8.2M | -117.3% |
| -0.9% |
| EPS (Basic) | -$47.93 | -2296.5% |
| EPS (Diluted) | -$47.93 | -2296.5% |